Delivery Order SPE2DR25D2012-SPE2DR26F1BHN
Award Date 11/3/25
Potential Completion Date 11/4/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,950.54 to AmerisourceBergen Drug Corp for XYOSTED 100 mg/0.5 mL auto-injector units on October 23, 2025, with completion scheduled for October 24, 2025. This competitively awarded, firm fixed-price delivery order represents a medical pharmaceutical supply to support federal healthcare operations. The product will be delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $1,203.36 to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 mL auto-injector supplies, with an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical product...
- The Defense Logistics Agency awarded a delivery order valued at $1,524.90 to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 ml auto-injector supplies on July 18, 2025, with completion targeted for July 21, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award based on capability. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical delivery order. This delivery order...
- The Defense Logistics Agency awarded a $1,306.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XYOSTED 75 MG/0.5 ML auto-injector vials on September 12, 2025, with completion by September 15, 2025. This non-set-aside competitive award represents a pharmaceutical supply delivery executed under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered...
- The Defense Logistics Agency awarded a delivery order valued at $1,150.15 to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 mL auto-injector supplies. The contract, which is non-set-aside and competitively awarded, was issued on August 1, 2025, with an ultimate completion date of August 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order operates under...
- The Defense Logistics Agency awarded a $1,494.88 delivery order to AmerisourceBergen Drug Corp for XYOSTED 50 mg/0.5 mL auto-injector supplies, with an ultimate completion date of June 20, 2025. This non-set-aside, firm fixed price delivery order was issued on June 18, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,158.24 to AmerisourceBergen Drug Corp for XYOSTED 100 mg/0.5 mL auto-injector supplies on October 8, 2025, with completion scheduled for October 9, 2025. This firm fixed price delivery order, issued without set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX). The pharmaceutical product will...
- The Defense Logistics Agency awarded a delivery order valued at $1,464.31 to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 mL auto-injector supplies. This competitively awarded, firm fixed-price contract was issued on June 4, 2025, with an ultimate completion date of June 5, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. No set-aside designation was applied to this award, indicating open competition among qualified...
- The Defense Logistics Agency has awarded a delivery order valued at $1,067.72 to AmerisourceBergen Drug Corp for XYOSTED 100 MG/0.5 ML auto-injector pharmaceutical supplies. The contract is a firm fixed price delivery order with an ultimate completion date of June 3, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability...
- The Defense Logistics Agency awarded a $4,435.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of XYOSTED 75 mg/0.5 mL auto-injector units. The contract, which was competitively awarded with no set-aside designation, has an ultimate completion date of October 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...